Management of adrenocortical carcinoma
S Jasim, MA Habra - Current oncology reports, 2019 - Springer
Abstract Purpose of Review Adrenocortical carcinoma (ACC) is a rare endocrine malignancy
typically with poor prognosis. This review aims to summarize the current knowledge …
typically with poor prognosis. This review aims to summarize the current knowledge …
Meta-analysis and systematic review of the genomics of mucosal melanoma
Mucosal melanoma is a rare subtype of melanoma. To date, there has been no
comprehensive systematic collation and statistical analysis of the aberrations and …
comprehensive systematic collation and statistical analysis of the aberrations and …
Oncogenic β-catenin stimulation of AKT2–CAD-mediated pyrimidine synthesis is targetable vulnerability in liver cancer
F Liu, X Gai, Y Wu, B Zhang, X Wu… - Proceedings of the …, 2022 - National Acad Sciences
CTNNB1, encoding β-catenin protein, is the most frequently altered proto-oncogene in
hepatic neoplasms. In this study, we studied the significance and pathological mechanism of …
hepatic neoplasms. In this study, we studied the significance and pathological mechanism of …
Wnt/β-catenin signaling pathway in the tumor progression of adrenocortical carcinoma
Y Tai, J Shang - Frontiers in Endocrinology, 2024 - frontiersin.org
Adrenocortical carcinoma (ACC) is an uncommon, aggressive endocrine malignancy with a
high rate of recurrence, a poor prognosis, and a propensity for metastasis. Currently, only …
high rate of recurrence, a poor prognosis, and a propensity for metastasis. Currently, only …
Primary cultures and cell lines for in vitro modeling of the human adrenal cortex
K Nanba, AR Blinder, WE Rainey - The Tohoku Journal of …, 2021 - jstage.jst.go.jp
The human adrenal cortex is a complex endocrine organ that produces mineralocorticoids,
glucocorticoids and androgens. These steroids are produced in distinct cell types located …
glucocorticoids and androgens. These steroids are produced in distinct cell types located …
Key MicroRNA's and their targetome in adrenocortical cancer
Adrenocortical Carcinoma (ACC) is a rare but aggressive malignancy with poor prognosis
and limited response to available systemic therapies. Although complete surgical resection …
and limited response to available systemic therapies. Although complete surgical resection …
Molecular genomic profiling of adrenocortical cancers in clinical practice
S Darabi, DR Braxton, BL Eisenberg, MJ Demeure - Surgery, 2021 - Elsevier
Abstract Background At presentation, 21% to 49% of patients with adrenocortical cancer
have metastases. Standard chemotherapy has a 23% response rate. We assessed whether …
have metastases. Standard chemotherapy has a 23% response rate. We assessed whether …
CCNB2 and AURKA overexpression may cause atypical mitosis in Japanese cortisol-producing adrenocortical carcinoma with TP53 somatic variant
A Ikeya, M Nakashima, M Yamashita, K Kakizawa… - PLoS …, 2020 - journals.plos.org
Background Many genomic analyses of cortisol-producing adrenocortical carcinoma (ACC)
have been reported, but very few have come from East Asia. The first objective of this study …
have been reported, but very few have come from East Asia. The first objective of this study …
Targeted Next Generation Sequencing molecular profiling and its clinical application in adrenocortical cancer
Objective Adrenal cortical carcinoma (ACC) is a rare malignancy with a generally poor but
heterogeneous prognosis, especially depending on the tumour stage at diagnosis …
heterogeneous prognosis, especially depending on the tumour stage at diagnosis …
Regulatory mechanism of ITGBL1 in the metastasis of colorectal cancer
L Qi, F Song, Y Ding - Frontiers in Oncology, 2020 - frontiersin.org
Integrin, beta-like 1 (ITGBL1) protein is located in the extracellular matrix (ECM) and
involved in the development and metastasis of many tumors. However, the regulatory …
involved in the development and metastasis of many tumors. However, the regulatory …